Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World"

Affiliations

¹ University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Zabrze, Poland.
² University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: g.y.h.lip@bham.ac.uk.

Editorial

Michał Mazurek et al. Gastroenterology. 2017 Apr.

. 2017 Apr;152(5):932-934.

doi: 10.1053/j.gastro.2017.02.027. Epub 2017 Mar 1.

¹ University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Zabrze, Poland.
² University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: g.y.h.lip@bham.ac.uk.

No abstract available

Comment on

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
Abraham NS, Noseworthy PA, Yao X, Sangaralingham LR, Shah ND. Abraham NS, et al. Gastroenterology. 2017 Apr;152(5):1014-1022.e1. doi: 10.1053/j.gastro.2016.12.018. Epub 2016 Dec 30. Gastroenterology. 2017. PMID: 28043907